Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) can cause serious immune-related adverse events (irAEs). This study aimed to identify risk factors for all types of irAEs induced by ICIs in patients with non-small-cell lung cancer (NSCLC), by systematic review and meta-analyses. METHODS: A systematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Suazo-Zepeda, E., Bokern, M., Vinke, P. C., Hiltermann, T. J. N., de Bock, G. H., Sidorenkov, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505368/
https://www.ncbi.nlm.nih.gov/pubmed/34195862
http://dx.doi.org/10.1007/s00262-021-02996-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505368/
https://www.ncbi.nlm.nih.gov/pubmed/34195862
http://dx.doi.org/10.1007/s00262-021-02996-3

Ejemplares similares